Controversies of radiation therapy omission in elderly women with early stage invasive breast cancer
Open Access
- 1 January 2020
- journal article
- review article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 9 (S1) , S126-S130
Abstract
Early stage invasive breast cancer is a disease that is prevalent in the elderly population. Data regarding radiation omission for elderly population is based on patients’ age. Given the increased life expectancy, data on individualizing treatment decisions based on multiple tumor and patient related factors other than age only is emerging. This review aims to analyze published data to provide clinicians with a general oversight on approaching this question.Keywords
This publication has 21 references indexed in Scilit:
- Management and Outcomes in Metaplastic Breast CancerClinical Breast Cancer, 2016
- Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward TrialRadiotherapy and Oncology, 2016
- Omission of Breast Radiotherapy in Low-risk Luminal A Breast Cancer: Impact on Health Care CostsClinical Oncology, 2016
- Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trialThe Lancet Oncology, 2015
- Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategiesExperimental Hematology & Oncology, 2013
- Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343Journal of Clinical Oncology, 2013
- Nomogram to Predict the Benefit of Radiation for Older Patients With Breast Cancer Treated With Conservative SurgeryJournal of Clinical Oncology, 2012
- Lumpectomy Plus Tamoxifen or Anastrozole With or Without Whole Breast Irradiation in Women With Favorable Early Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast CancerNew England Journal of Medicine, 2004
- Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or LessJournal of Clinical Oncology, 2002